查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827766

2025年基于NGS的RNA定序全球市场报告

NGS-Based RNA-Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基于NGS的RNA定序市场规模呈指数级成长，从2024年的34.1亿美元成长到2025年的42亿美元，复合年增长率为23.3%。预测期内的成长主要受基因组研究计画、定序成本下降、药物研发、个人化医疗以及NGS应用的不断普及等因素所驱动。

预计未来几年，基于NGS的RNA定序市场将呈指数级增长，到2029年将达到102.6亿美元，复合年增长率为25.0%。预测期内的成长主要受临床诊断、国际合作研究、伦理和监管框架、农业和环境研究以及绿色基因组学的推动。预测期内的主要趋势包括单细胞RNA定序（scRNA-seq）、空间转录组学、表观转录组学、多体学整合以及永续农业。

基于NGS的RNA定序是一种利用次世代定序仪（NGS）技术，用于识别和量化特定时刻生物样本中核糖核酸（RNA）的含量。 NGS采用大规模平行定序技术，具有极高的通量、可扩展性和速度，可用于测定整个基因组或特定DNA/RNA片段的序列。

基于NGS的RNA定序的关键产品和服务包括样品製备产品、定序平台和耗材、定序服务、数据分析、储存和管理。样品製备产品有助于将DNA或RNA连接到定序流动槽上，从而实现样品鑑定。样品製备过程将生物样本中的核酸混合物转化为各种文库，并为NGS技术做好准备。 NGS涉及的技术包括边合成边定序、离子半导体定序、单分子即时定序和奈米孔定序。这些定序方法应用于表达谱分析、小RNA定序、从头转录组组装、变异检测和转录组表观遗传学。基于NGS的RNA定序被各种终端用户使用，包括研究和学术机构、医院诊所、製药和生物技术公司以及科学界的其他营业单位。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快研发更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供基于 NGS 的 RNA 测序市场统计数据，包括全球市场规模、各地区份额、竞争对手的市场份额、基于 NGS 的 RNA 测序细分市场、市场趋势和商业机会，以及在基于 NGS 的 RNA 测序行业取得成功所需的其他数据。本研究报告详细分析了基于 NGS 的 RNA 定序产业的现状和未来趋势，为您提供全面的观点。

我们预测未来五年该市场将成长25.0%，较先前预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这直接影响了美国，包括对芬兰高保真逆转录酶的贸易限制，这提高了转录组学研究的成本，并可能减缓个人化癌症和罕见疾病治疗的突破。此外，由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

精准医疗的扩张正在推动基于NGS的RNA定序市场的成长。精准医疗帮助医疗保健提供者制定个人化治疗方案，并根据对患者病情的基因理解做出决策。精准医疗在治疗癌症等严重方面日益受到关注。基于NGS的RNA定序有助于识别疾病的根本原因并建议特定的精准治疗方案。例如，根据美国非营利组织个人化医疗联盟 (PMC) 2023年2月的报告，2021年新核准的新型分子药物 (NME) 中有35%是个人化药物。 2022年有12个新核准，这一数字在过去八年中一直占新药认证的四分之一以上，与十年前不到10%的比例相比有显着增长。随着精准医疗需求的持续成长，基于NGS的RNA定序的需求也将随之成长。

不断扩张的製药业预计将推动基于 NGS 的 RNA 测序市场的未来成长。製药业包括公共和私人机构对药物和药品的发现、开发和生产。基于 NGS 的 RNA 定序用于彻底分析基因表现，识别潜在的药物标靶，评估药物反应，并阐明疾病机制，透过更深入地了解分子过程来增强药物的发现和开发。例如，美国ABA 治疗服务供应商 Cross River Therapy 于 2024 年 9 月发布的统计数据显示，美国製药业的销售额为 5,500 亿美元，美国在 2021 年的药物支出为 5,769 亿美元。预计到 2025 年，这一数字将从 6,050 亿美元增至 6,350 亿美元。因此，製药业的成长正在推动基于 NGS 的 RNA 定序市场的扩张。

基于NGS的RNA定序市场的一个显着趋势是策略伙伴关係关係的形成。越来越多的企业与基于NGS的RNA测序公司伙伴关係，以进入新市场并利用综合资源。例如，2022年5月，美国生物医学高级研究与发展管理局（BARDA）与多家产学研机构合作，以加强对呼吸道RNA病毒的诊断能力。此类策略伙伴关係增强了快速应对突发公共卫生事件的能力，并有助于提高诊断能力。

基于NGS的RNA定序市场的主要企业正专注于创新产品，以满足日益增长的RNA定序需求。其中一项创新是开发用于分子检测和生命科学研究的超快速RNA方法，提供极快的RNA定序和分析。 2022年3月，Quantabio推出了sparQ RNA-Seq HMR Kit，这是一款专为精准肿瘤学设计的超快速RNA文库製备工具。此套件可在一天内从完整或劣化的样本中产生高品质的可用于NGS定序仪的文库。

2022年10月，专注于DNA定序和晶片技术的美国公司Illumina宣布与GenoScreen建立合作关係。此次合作旨在透过扩大多重抗药性结核病（MDR-TB）基因组检测的可及性，以及更快速有效地检测抗药性，支持全球对抗结核病的斗争，尤其是在结核病高负担国家。 GenoScreen是一家总部位于法国的公司，专注于定序、基因型鉴定和生物资讯学。

以 NGS 为基础的 RNA 定序市场的主要企业包括 Illumina Inc.、Thermo Fisher Scientific Inc.、Oxford Nanopore Technologies Ltd.、Agilent Technologies Inc.、BGI Group、QIAGEN NV、PerkinElmer Inc.、Eurofins Scientific SE、Bio-Rad Laborator Inc.、F. Hmann Inc.、Eurofins Scientific SE、Bio-Rad Laborator Inc.、F. Hmann Inc. AG、GENEWIZ Inc.、Novogene Corporation、Macrogen Inc.、Zymo Research Corp.、Lexogen GmbH、Partek Incorporated、GATC BIoTech AG、Becton、Dickinson and Company、Genohub LLC、BaseClear BV、Genewave SAS、Otogenetics Corporation、GenqLL LLC、XXersPropot​​y Got​​o Got M​​T.

2024年，北美是NGS RNA定序市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。基于NGS的RNA定序市场分析报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

基于 NGS 的 RNA 定序市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

基于NGS的RNA定序市场涵盖多种小型ncRNA（例如核醣体RNA (rRNA)、转移RNA (tRNA)、长链ncRNA和微型RNA）产生的收益。市场规模还包括服务供应商销售或包含在其服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基于NGS的RNA定序：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球基于NGS的RNA定序市场：成长率分析
  • 全球基于NGS的RNA定序市场表现：规模与成长，2019-2024年
  • 全球基于NGS的RNA定序市场预测：规模与成长，2024-2029年，2034年
  • 全球基于NGS的RNA定序：总潜在市场（TAM）

第六章 市场细分

  • 全球基于NGS的RNA定序市场（依产品与服务、绩效及预测），2019-2024年、2024-2029年、2034年
  • 样品製备产品
  • 定序平台和耗材
  • 定序服务
  • 数据分析、储存和管理
  • 全球基于NGS的RNA定序市场（依技术、效能和预测），2019-2024年、2024-2029年和2034年
  • 边合成边定序
  • 离子半导体序列
  • 单分子即时定序
  • 奈米孔定序
  • 全球基于NGS的RNA定序市场（按应用、效能和预测），2019-2024年、2024-2029年和2034年
  • 表达谱分析
  • 小RNA定序
  • 从头转录组组装
  • 变异调用和转录组表观遗传学
  • 全球基于NGS的RNA定序市场（按最终用户、表现和预测），2019-2024年、2024-2029年和2034年
  • 研究与学术
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的
  • 全球基于NGS的RNA定序市场：样品製备产品细分，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • RNA萃取试剂套件
  • 文库製备试剂套件
  • 逆转录试剂套件
  • 品管试剂
  • 全球基于 NGS 的 RNA 定序市场：定序平台和耗材细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 定序设备
  • 定序耗材
  • 全球基于 NGS 的 RNA 定序市场：定序服务细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 合约排序服务
  • 客製化文库製备服务
  • 咨询和实验设计服务
  • 全球基于NGS的RNA定序市场：资料分析、储存和管理细分，按类型、效能和预测，2019-2024年、2024-2029年、2034年
  • 生物资讯软体
  • 数据分析服务
  • 云端基础的资料储存解决方案
  • 资料管理平台

第七章 区域和国家分析

  • 全球基于 NGS 的 RNA 定序市场：区域表现和预测（2019-2024 年、2024-2029 年和 2034 年）
  • 全球基于 NGS 的 RNA 定序市场：国家、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 基于NGS的RNA定序市场：竞争格局
  • 基于NGS的RNA定序市场：公司简介
    • Illumina Inc.
    • Thermo Fisher Scientific Inc.
    • Oxford Nanopore Technologies Ltd.
    • Agilent Technologies Inc.
    • BGI Group

第31章：其他领先和创新企业

  • QIAGEN NV
  • PerkinElmer Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hamilton Company
  • Takara Bio Inc.
  • Tecan Trading AG
  • GENEWIZ Inc.
  • Novogene Corporation
  • Macrogen Inc.
  • Zymo Research Corp.
  • Lexogen GmbH
  • Partek Incorporated
  • GATC BIoTech AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年基于NGS的RNA定序市场：提供新机会的国家
  • 2029年基于NGS的RNA定序市场：细分领域带来新机会
  • 2029年基于NGS的RNA定序市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21852u

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The NGS-based RNA sequencing market research report is one of a series of new reports from The Business Research Company that provides NGS-based RNA sequencing market statistics, including NGS-based RNA sequencing industry global market size, regional shares, competitors with a NGS-based RNA sequencing market share, detailed NGS-based RNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the NGS-based RNA sequencing industry. This NGS-based RNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ngs-based rna-sequencing market size has grown exponentially in recent years. It will grow from $3.41 billion in 2024 to $4.2 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to genomic research initiatives, reduction in sequencing costs, drug discovery and development, personalized medicine, increasing ngs adoption.

The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $10.26 billion in 2029 at a compound annual growth rate (CAGR) of 25.0%. The growth in the forecast period can be attributed to clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, green genomics. Major trends in the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, sustainable agriculture.

The forecast of 25.0% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through trade restrictions on high-fidelity reverse transcriptase enzymes from Finland, raising costs for transcriptomic research and potentially slowing breakthroughs in personalized cancer and rare disease therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expansion of precision medicine is propelling the growth of the NGS-based RNA sequencing market. Precision medicine assists healthcare providers in creating tailored treatment plans and making decisions based on a genetic understanding of the patient's condition. There is an increasing focus on precision medicines for addressing serious diseases such as cancer. NGS-based RNA sequencing is instrumental in identifying the underlying causes of diseases and recommending specific precision treatments. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently accounted for at least a quarter of new drug approvals over the past eight years, marking a substantial rise from less than 10% a decade ago. As the demand for precision medicines continues to grow, so too will the demand for NGS-based RNA sequencing.

The expanding pharmaceutical industry is anticipated to drive the growth of the NGS-based RNA sequencing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both public and private organizations. NGS-based RNA sequencing is utilized within this sector to conduct thorough analyses of gene expression, identify potential drug targets, evaluate drug responses, and comprehend disease mechanisms, thereby enhancing drug discovery and development through a better understanding of molecular processes. For instance, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, revealed that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medications in 2021. Projected spending is expected to rise to between $605 billion and $635 billion by 2025. Consequently, the growth of the pharmaceutical industry is propelling the expansion of the NGS-based RNA sequencing market.

A notable trend in the NGS-based RNA sequencing market is the formation of strategic partnerships. Companies are increasingly engaging in partnerships with NGS-based RNA sequencing firms to enter new markets and leverage collective resources. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA) partnered with multiple industry and academic collaborators to enhance diagnostic capabilities for respiratory RNA viruses. Such strategic partnerships contribute to bolstering the capacity to respond swiftly to public health emergencies and advance diagnostic capabilities.

Major companies in the NGS-based RNA-sequencing market are concentrating on innovative products to meet the growing demand for RNA sequencing. One such innovation is the development of ultra-fast RNA methods for molecular testing and life science research applications, offering exceptionally rapid RNA sequencing or analysis. In March 2022, Quantabio launched the sparQ RNA-Seq HMR Kit, an ultra-fast RNA library preparation tool designed for precision oncology applications. This kit enables the generation of high-quality NGS sequencer-ready libraries from intact or degraded samples in a single day.

In October 2022, Illumina Inc., a US-based company specializing in DNA sequencing and array-based technology, announced a collaboration with GenoScreen. This partnership seeks to enhance access to genomic testing for multidrug-resistant tuberculosis (MDR-TB), facilitating faster and more effective detection of drug resistance to aid in the global fight against TB, particularly in countries severely affected by the disease. GenoScreen is a France-based company focused on sequencing, genotyping, and bioinformatics.

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in NGS-based RNA sequencing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the NGS-based RNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
  • 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
  • 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly; Variant Calling and Transcriptome Epigenetics
  • 4) By End User: Research & Academia; Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
  • 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
  • 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
  • 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group; QIAGEN N.V.; PerkinElmer Inc.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; Hamilton Company; Takara Bio Inc.; Tecan Trading AG; GENEWIZ Inc.; Novogene Corporation; Macrogen Inc.; Zymo Research Corp.; Lexogen GmbH; Partek Incorporated; GATC Biotech AG; Becton, Dickinson and Company; Genohub LLC; BaseClear B.V.; Genewave SAS; Otogenetics Corporation; SeqLL LLC; GenXPro GmbH; Genotypic Technology Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. NGS-Based RNA-Sequencing Market Characteristics

3. NGS-Based RNA-Sequencing Market Trends And Strategies

4. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global NGS-Based RNA-Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global NGS-Based RNA-Sequencing Market Growth Rate Analysis
  • 5.4. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM)

6. NGS-Based RNA-Sequencing Market Segmentation

  • 6.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Preparation Products
  • Sequencing Platforms and Consumables
  • Sequencing Services
  • Data Analysis, Storage, and Management
  • 6.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • 6.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling and Transcriptome Epigenetics
  • 6.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research & Academia
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users
  • 6.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNA Extraction Kits
  • Library Preparation Kits
  • Reverse Transcription Kits
  • Quality Control Reagents
  • 6.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Instruments
  • Sequencing Consumables
  • 6.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contract Sequencing Services
  • Custom Library Preparation Services
  • Consultation And Experimental Design Services
  • 6.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioinformatics Software
  • Data Analysis Services
  • Cloud-Based Data Storage Solutions
  • Data Management Platforms

7. NGS-Based RNA-Sequencing Market Regional And Country Analysis

  • 7.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 8.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China NGS-Based RNA-Sequencing Market

  • 9.1. China NGS-Based RNA-Sequencing Market Overview
  • 9.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India NGS-Based RNA-Sequencing Market

  • 10.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan NGS-Based RNA-Sequencing Market

  • 11.1. Japan NGS-Based RNA-Sequencing Market Overview
  • 11.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia NGS-Based RNA-Sequencing Market

  • 12.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia NGS-Based RNA-Sequencing Market

  • 13.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea NGS-Based RNA-Sequencing Market

  • 14.1. South Korea NGS-Based RNA-Sequencing Market Overview
  • 14.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe NGS-Based RNA-Sequencing Market

  • 15.1. Western Europe NGS-Based RNA-Sequencing Market Overview
  • 15.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK NGS-Based RNA-Sequencing Market

  • 16.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany NGS-Based RNA-Sequencing Market

  • 17.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France NGS-Based RNA-Sequencing Market

  • 18.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy NGS-Based RNA-Sequencing Market

  • 19.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain NGS-Based RNA-Sequencing Market

  • 20.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe NGS-Based RNA-Sequencing Market

  • 21.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
  • 21.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia NGS-Based RNA-Sequencing Market

  • 22.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America NGS-Based RNA-Sequencing Market

  • 23.1. North America NGS-Based RNA-Sequencing Market Overview
  • 23.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA NGS-Based RNA-Sequencing Market

  • 24.1. USA NGS-Based RNA-Sequencing Market Overview
  • 24.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada NGS-Based RNA-Sequencing Market

  • 25.1. Canada NGS-Based RNA-Sequencing Market Overview
  • 25.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America NGS-Based RNA-Sequencing Market

  • 26.1. South America NGS-Based RNA-Sequencing Market Overview
  • 26.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil NGS-Based RNA-Sequencing Market

  • 27.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East NGS-Based RNA-Sequencing Market

  • 28.1. Middle East NGS-Based RNA-Sequencing Market Overview
  • 28.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa NGS-Based RNA-Sequencing Market

  • 29.1. Africa NGS-Based RNA-Sequencing Market Overview
  • 29.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. NGS-Based RNA-Sequencing Market Competitive Landscape
  • 30.2. NGS-Based RNA-Sequencing Market Company Profiles
    • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

31. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. PerkinElmer Inc.
  • 31.3. Eurofins Scientific SE
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. F. Hoffmann-La Roche Ltd.
  • 31.6. Hamilton Company
  • 31.7. Takara Bio Inc.
  • 31.8. Tecan Trading AG
  • 31.9. GENEWIZ Inc.
  • 31.10. Novogene Corporation
  • 31.11. Macrogen Inc.
  • 31.12. Zymo Research Corp.
  • 31.13. Lexogen GmbH
  • 31.14. Partek Incorporated
  • 31.15. GATC Biotech AG

32. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

34. Recent Developments In The NGS-Based RNA-Sequencing Market

35. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 NGS-Based RNA-Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 NGS-Based RNA-Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 NGS-Based RNA-Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer